Based on your survey input, we’ve updated the #RegenMed #standards portal with new and revised areas of need. See them all: https://bit.ly/3g4pgCz
Standards Coordinating Body (SCB)
非盈利组织
Gaithersburg，MD 847 位关注者
Connecting the regenerative medicine community to the standards development process.
关于我们
The Standards Coordinating Body for Gene, Cell, and Regenerative Medicines and Cell-Based Drug Discovery (SCB) is a non-profit organization that connects the regenerative medicine community to the standards development process. With stakeholders from industry, academia, professional societies, and government entities, SCB occupies a unique niche within the regenerative medicine ecosystem and has no vested interests in a particular scientific, commercial, clinical, or policy approach. Our goal is to address stakeholder needs and support the advancement of standards that enhance the entire regenerative medicine community and accelerate innovation.
- 网站
-
https://www.standardscoordinatingbody.org/
Standards Coordinating Body (SCB)的外部链接
- 所属行业
- 非盈利组织
- 规模
- 2-10 人
- 总部
- Gaithersburg，MD
- 类型
- 非营利机构
- 创立
- 2016
地点
-
主要
获取路线
100 Bureau Drive
US，MD，Gaithersburg，20899
Standards Coordinating Body (SCB)员工
动态
-
STANDARD UPDATE: Updates to #standards from ISO - International Organization for Standardization ASTM International and more have been added to the SCB #RegenMed Standards Portal. See all 389 standards: https://bit.ly/3g4pgCz
-
-
We’ve launched new #standards draft consortia to help experts easily provide input on multiple #regenerativemedicine standards without a major time commitment. Learn more: https://bit.ly/4aEBBZS
-
-
STANDARD UPDATE: Updates to #standards from ISO - International Organization for Standardization, ASTM International and more have been added to the SCB #RegenMed Standards Portal. See all 389 standards: https://bit.ly/3g4pgCz
-
-
SEEKING EXPERTS: Share your perspective at a February #regenmed #standards feasibility assessment meeting. These meetings help us determine whether a topic is ready for standardization. Register: https://bit.ly/3C9tZlh
-
-
STANDARD UPDATE: Updates to #standards from @isostandards @ASTMIntl and more have been added to the SCB #RegenMed Standards Portal. See all 389 standards: https://bit.ly/3g4pgCz
-
-
SURVEY ENDING SOON: Help us prioritize topics for future #RegenerativeMedicine #standards coordination efforts. https://bit.ly/35ErlDk #CellTherapy #GeneTherapy #TissueEngineering
-
-
ICYMI: Take a short survey on needed #standards to help us prioritize topics for future #RegenerativeMedicine standards coordination efforts. https://bit.ly/35ErlDk #CellTherapy #GeneTherapy #TissueEngineering
-
-
Standards Coordinating Body (SCB)转发了
Students, Applications are now open for the NIIMBL eXperience program in summer 2025. This is an opportunity for college students from underrepresented populations to have hands-on trainings at a number of different institutions around the U.S. I would highly recommend this opportunity to students who have just started their academic journey and have an interest in biochemistry and/or pharmaceutical manufacturing. Please share with college students in your life :) The experiences are about a week long and each is slightly different. Please visit the link below for more information on each site/experience, requirements for the application, and to apply: https://lnkd.in/gZQVyEv9
-
Standards Coordinating Body (SCB)转发了
Co-Founder: Board Member @Akron Bio I Board Chair @Arscience Bio | Board Chair @Kosten Digital
This Monday, November 25th at 10 AM ET, I am excited to moderate a session delving into crucial topics with a distinguished panel of experts: - Ensuring data quality and diversity - Highlighting the importance of model interpretability - Discussing generalization and transferability of AI models - Navigating ethical, legal, and regulatory landscapes - Establishing trust in AI solutions and addressing skepticism around AI adoption Join @Angela Lai, Dalip Sethi, PhD, MBA, Eduard Kliphuis, Yochi Slonim, and myself for an enlightening and stimulating discussion. Don’t miss this opportunity to engage in valuable insights. Link to the session: https://lnkd.in/dbeaRtPf